A critical discovery in cancer research is emerging with the use of nanobodies to reactivate dysfunctional p53. This vital tumor protector protein is frequently disabled in various kinds of tumors, leading uncontrolled https://mylittlebookmark.com/story7760959/mini-antibodies-restore-the-p53-protein-a-potential-hope-for-cancer-management